Small Molecules

25 Apr 2007 Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
25 Apr 2007 Lexicon Advances LX1031 for Irritable Bowel Syndrome into Phase 1b Clinical Trial
25 Apr 2007 Ceragenix Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints
25 Apr 2007 Pharmos Announces Clinical Data from Phase 2a Trial of Cannabinor for Nociceptive Pain in Third Molar Dental Extraction Model
25 Apr 2007 Exelixis Reinitiates Clinical Development of XL999 in Patients With Non-Small Cell Lung Cancer
25 Apr 2007 Provectus Pharmaceuticals, Inc. Completes Dosing of Patients in Phase 1 Melanoma Study
25 Apr 2007 Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
25 Apr 2007 FDA Advisory Committee Recommends Accelerated Approval of Pfizer's Maraviroc for Treatment-Experienced Patients
24 Apr 2007 Oral Azacitidine Advances to Multi-Center, Multi-Cycle, Dose Escalation Study
24 Apr 2007 Application for an Additional Indication of Combination Therapy of Glufast(R) and Insulin Sensitizer in Japan
24 Apr 2007 Alimera Sciences' Medidur(TM) Trial Exceeds 500 Patient Mark In Phase 3 Trial Enrollment
24 Apr 2007 Pharmacyclics Announces FDA Filing of New Drug Application for Xcytrin(R) Injection to Treat Lung Cancer Brain Metastases
24 Apr 2007 Targeting Specific Mutations Reveals Promising New Approach to Treating Genetic Disorders; Preclinical Data Published in Nature
24 Apr 2007 AstraZeneca announces decision to discontinue collaboration with AtheroGenics regarding AGI-1067
24 Apr 2007 Synosia Therapeutics Announces Second Major Pharmaceutical Deal
24 Apr 2007 Ceragenix Announces New Publication of Scientific Research on Ceragenin(TM) Technology
24 Apr 2007 Bionomics completes GMP synthesis of cancer drug BNC105 on time and on budget
24 Apr 2007 Vectura Announces Successful Outcome of Second Phase IIb Clinical Study on Inhaled Erectile Dysfunction Product
21 Apr 2007 FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
21 Apr 2007 Addex reports positive results in Phase IIa clinical trial with ADX10059 in Migraine
21 Apr 2007 UCB Announces Positive Top-Line Phase III Results for Keppra as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
21 Apr 2007 Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential to Accelerate Recovery of Bone Marrow Stem Cells Following Cancer Radiation Therapy
20 Apr 2007 Novartis expands late-stage oncology pipeline with AS1404, a novel agent shown to break down blood vessels that support tumor growth
20 Apr 2007 Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment of HCV
20 Apr 2007 CuraGen and TopoTarget Present New Clinical Results with Belinostat at the Annual Meeting in ASCO and at the conference "2007 Pan Pacific Lymphoma"

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up